Curaleaf Holdings (CURLF) EBITDA Margin (2019 - 2026)

Curaleaf Holdings has reported EBITDA Margin for 8 years, with the latest figure at 7.14% in Q2 2026.

• On a quarterly basis, EBITDA Margin fell 165.0% year-over-year to 7.14% in Q2 2026; TTM through Jun 2026 was 3.01%, a 15.0% increase from a year earlier, with the FY2025 full-year figure at 8.62%, up 53.0% from the prior year.
• EBITDA Margin was 7.14% for Q2 2026 at Curaleaf Holdings, up from 0.23% in the prior quarter.
• The five-year high for EBITDA Margin was 10.73% in Q2 2022, with the low at 10.83% in Q4 2022.
• Average EBITDA Margin over 5 years is 3.4%, with a median of 3.47% recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: EBITDA Margin tumbled 1423 bps in 2022, then surged 1487 bps in 2023.
• Over 5 years, EBITDA Margin stood at 10.83% in 2022, then soared by 137 bps to 4.05% in 2023, then slumped by 169 bps to 2.8% in 2024, then jumped by 214 bps to 3.19% in 2025, then soared by 124 bps to 7.14% in 2026.
• The last three EBITDA Margin figures came in at 7.14% (Q2 2026), 0.23% (Q1 2026), and 3.19% (Q4 2025), per Business Quant data.